BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 28741377)

  • 1. Renal Cell Carcinoma: Alternative Nephron-Sparing Treatment Options for Small Renal Masses, a Systematic Review.
    Prins FM; Kerkmeijer LGW; Pronk AA; Vonken EPA; Meijer RP; Bex A; Barendrecht MM
    J Endourol; 2017 Oct; 31(10):963-975. PubMed ID: 28741377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
    Uhlig A; Uhlig J; Trojan L; Kim HS
    J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
    El Dib R; Touma NJ; Kapoor A
    BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous image-guided cryoablation of small renal masses.
    Patel N; King AJ; Breen DJ
    Abdom Radiol (NY); 2016 Apr; 41(4):754-66. PubMed ID: 26915090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small renal tumors: natural history, observation strategies and emerging modalities of energy based tumor ablation.
    Derweesh IH; Novick AC
    Can J Urol; 2003 Jun; 10(3):1871-9. PubMed ID: 12892573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Available ablation energies to treat cT1 renal cell cancer: emerging technologies.
    Zondervan PJ; Buijs M; De Bruin DM; van Delden OM; Van Lienden KP
    World J Urol; 2019 Mar; 37(3):445-455. PubMed ID: 30448873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New technologies in tumor ablation.
    Singla N; Gahan J
    Curr Opin Urol; 2016 May; 26(3):248-53. PubMed ID: 26967263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Focal therapy for small renal masses : Observation, ablation or surgery].
    Wendler JJ; Friebe B; Baumunk D; Blana A; Franiel T; Ganzer R; Hadaschik B; Henkel T; Köhrmann KU; Köllermann J; Kuru T; Machtens S; Roosen A; Salomon G; Schlemmer HP; Sentker L; Witzsch U; Liehr UB; Ricke J; Schostak M
    Urologe A; 2016 May; 55(5):594-606. PubMed ID: 27119957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.
    Kunkle DA; Egleston BL; Uzzo RG
    J Urol; 2008 Apr; 179(4):1227-33; discussion 1233-4. PubMed ID: 18280512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis.
    Uhlig J; Strauss A; Rücker G; Seif Amir Hosseini A; Lotz J; Trojan L; Kim HS; Uhlig A
    Eur Radiol; 2019 Mar; 29(3):1293-1307. PubMed ID: 30255245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal ablation of the small renal mass: a critical analysis of current literature.
    Mershon JP; Tuong MN; Schenkman NS
    Minerva Urol Nefrol; 2020 Apr; 72(2):123-134. PubMed ID: 31833721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses.
    Salagierski M; Wojciechowska A; Zając K; Klatte T; Thompson RH; Cadeddu JA; Kaouk J; Autorino R; Ahrar K; Capitanio U;
    Eur Urol Oncol; 2018 Oct; 1(5):395-402. PubMed ID: 31158078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and outcomes of tumor recurrence after focal ablation renal therapy.
    Breda A; Anterasian C; Belldegrun A
    J Endourol; 2010 May; 24(5):749-52. PubMed ID: 20443716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally invasive nephron-sparing surgery.
    Berger A; Crouzet S; Canes D; Haber GP; Gill IS
    Curr Opin Urol; 2008 Sep; 18(5):462-6. PubMed ID: 18670268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ablative therapy of small renal masses].
    Kriegmair MC; Wagener N; Diehl SJ; Rathmann N
    Urologe A; 2018 Mar; 57(3):285-294. PubMed ID: 29396626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized renal cell carcinoma management: an update.
    Heldwein FL; McCullough TC; Souto CA; Galiano M; Barret E
    Int Braz J Urol; 2008; 34(6):676-89; discussion 689-90. PubMed ID: 19111072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis.
    Kunkle DA; Uzzo RG
    Cancer; 2008 Nov; 113(10):2671-80. PubMed ID: 18816624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Renal Parenchymal Volume Preservation Between Partial Nephrectomy, Cryoablation, and Radiofrequency Ablation Using 3D Volume Measurements.
    Woldu SL; Thoreson GR; Okhunov Z; Ghandour R; Rothberg MB; RoyChoudhury A; Kim HH; Bozoghlanian M; Newhouse JH; Helmy MA; Badani KK; Landman J; Cadeddu JA; McKiernan JM
    J Endourol; 2015 Aug; 29(8):948-55. PubMed ID: 25578645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.